EISAI INC. for EISAI INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; pharmaceutical scheduling; Pharmacy benefit managers (PBM) reform; S.891, Bipartisan Health Care Act, improvements to the 340B drug discount program; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BROOKS | — |
| TRICIA BROOKS | — |
| AMANDA MAJOR | — |
Medicare/Medicaid MMM
General issues related to Medicare and Medicaid, including: Part D Medicare Program; drug pricing; Inflation Reduction Act of 2022 (P.L.117-169) implementation. Issues related to pharmaceutical intellectual property.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BROOKS | — |
| TRICIA BROOKS | — |
| AMANDA MAJOR | — |
Taxation/Internal Revenue Code TAX
Issues related to tax reform. Research and Development tax credit; Section 899; H.R.1, One Big Beautiful Bill Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BROOKS | — |
| TRICIA BROOKS | — |
| AMANDA MAJOR | — |
Trade (domestic/foreign) TRD
Issues related to supply chain and tariffs. Section 232 tariff investigation on branded pharmaceuticals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BROOKS | — |
| TRICIA BROOKS | — |
| AMANDA MAJOR | — |
Budget/Appropriations BUD
H.R.1, One Big Beautiful Bill Act, all bio-pharmaceutical related provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BROOKS | — |
| TRICIA BROOKS | — |
| AMANDA MAJOR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.